P2X₇ receptor in the hippocampus is involved in gp120-induced cognitive dysfunction

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• HIV-1-associated dementia (HAD) is a severe neurological complication of HIV-1 infection.
• The HIV-1 envelope glycoprotein gp120 is implicated in neuroinflammation and cognitive impairment.
• The role of the P2X7 receptor in gp120-induced neurological dysfunction requires further investigation.

Purpose of the Study:

• To investigate the involvement of the P2X7 receptor in learning and memory deficits induced by HIV-1 gp120.
• To establish a rat model of HAD using intracerebroventricular (ICV) infusion of gp120.
• To analyze the expression levels of P2X7 receptor in the hippocampus of gp120-treated rats.

Main Methods:

• Establishment of HAD rat models via ICV infusion of gp120.
• Assessment of cognitive function using the radial arm water maze test.
• Quantification of P2X7 mRNA and protein expression in the hippocampus using RT-qPCR and immunohistochemistry.

Main Results:

• gp120 infusion led to significant cognitive dysfunction in rats, characterized by increased escape latencies and errors in the radial arm water maze.
• Relative mRNA and protein expression of P2X7 significantly increased in the hippocampus of gp120-treated rats compared to controls.
• Immunohistochemistry confirmed elevated P2X7 protein expression and staining intensity in the hippocampus of gp120 groups.

Conclusions:

• ICV infusion of gp120 successfully models HAD-like cognitive dysfunction in rats.
• The P2X7 receptor is upregulated in the hippocampus following gp120 exposure.
• P2X7 receptor signaling is implicated in gp120-induced cognitive impairment, suggesting it as a potential therapeutic target for HAD.